Fosamprenavir (Lexiva, Telzir)

Published October 30, 2003; Updated January 28, 2015
Susa Coffey, MD
Selected Reference
3. DeJesus E, LaMarca A, Sension M, Beltran C, Yeni P. The Context Study: Efficacy and Safety of GW433908/RTV in PI-experienced Subjects with Virological Failure (24 Week Results). 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 10-14, 2003. Abstract 178.